Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2015

01.12.2015 | Endocrine Tumors

Intraoperative Parathormone Monitoring Mitigates Age-Related Variability in Targeted Parathyroidectomy for Patients with Primary Hyperparathyroidism

verfasst von: Brian Bishop, BS, Bo Wang, MD, Punam P. Parikh, MD, John I. Lew, MD, FACS

Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Preoperative parathyroid localization studies, namely, sestamibi (MIBI) and surgeon-performed ultrasound (SUS), are commonly used for targeted parathyroidectomy (PTX) with intraoperative parathormone monitoring (IPM) in patients with primary hyperparathyroidism (pHPT). This study examined age-related variability in abnormal parathyroid gland localization for targeted PTX and the value of IPM across age groups.

Methods

A retrospective review examined prospectively collected data of 833 patients who underwent targeted PTX guided by IPM. The patients were stratified into three age groups as follows: younger [<47 years; mean −1 standard deviation (SD)], typical (47–73 years), and older (>73 years; mean +1 SD) based on an age distribution curve for pHPT. The accuracy, sensitivity, and positive predictive value (PPV) for MIBI, SUS, and IPM were analyzed and compared among age groups. Operative success was defined as eucalcemia for 6 months or longer after PTX, and operative failure was defined as elevated calcium and PTH levels within 6 months after PTX.

Results

Of the 833 patients, the youngest group had the highest accuracy and sensitivity for MIBI, SUS, and IPM compared with the older groups (p < 0.05). The accuracy and sensitivity of MIBI and SUS also decreased significantly with increased age (p < 0.05). Within all three age groups, IPM was consistently more accurate and sensitive than SUS or MIBI (p < 0.05).

Conclusions

Age can significantly affect the accuracy and sensitivity of MIBI and SUS in targeted PTX for patients with pHPT. Across all age groups, IPM remains more accurate than preoperative localization studies. For the elderly, in whom multiglandular disease appears increased, surgeons should have a lower threshold for conversion to bilateral neck exploration.
Literatur
1.
Zurück zum Zitat Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171–7.PubMedCrossRef Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171–7.PubMedCrossRef
2.
Zurück zum Zitat Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32:795–9.PubMedCrossRef Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32:795–9.PubMedCrossRef
3.
Zurück zum Zitat Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL III, Lew JI. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155:100–103.PubMedCrossRef Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL III, Lew JI. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155:100–103.PubMedCrossRef
4.
Zurück zum Zitat Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, et al. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly. 2009;139:400–4.PubMed Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, et al. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly. 2009;139:400–4.PubMed
6.
Zurück zum Zitat Centers for Disease Control and Prevention. Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101–24. Centers for Disease Control and Prevention. Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101–24.
7.
Zurück zum Zitat Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg. 1992; 215:300–17.PubMedPubMedCentralCrossRef Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg. 1992; 215:300–17.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 Consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80.PubMedCrossRef Allendorf J, DiGorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 Consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–80.PubMedCrossRef
9.
Zurück zum Zitat Irvin GL III, Deriso GT III. A new, practical intraoperative parathyroid hormone assay. Am J Surg. 1994;168:466–8.PubMedCrossRef Irvin GL III, Deriso GT III. A new, practical intraoperative parathyroid hormone assay. Am J Surg. 1994;168:466–8.PubMedCrossRef
10.
Zurück zum Zitat Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–70; (discussion 670–662). Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665–70; (discussion 670–662).
11.
Zurück zum Zitat Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137:186–90.PubMedCrossRef Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137:186–90.PubMedCrossRef
12.
Zurück zum Zitat Irvin GL III, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704–8; (discussion 708–11). Irvin GL III, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704–8; (discussion 708–11).
13.
Zurück zum Zitat Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8; (discussion 478–9). Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472–8; (discussion 478–9).
14.
Zurück zum Zitat Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7; (discussion 587–90). Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7; (discussion 587–90).
15.
Zurück zum Zitat Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med. 2002;21:539–52; (quiz 553–534). Reeder SB, Desser TS, Weigel RJ, Jeffrey RB. Sonography in primary hyperparathyroidism: review with emphasis on scanning technique. J Ultrasound Med. 2002;21:539–52; (quiz 553–534).
16.
Zurück zum Zitat Van Husen R, Kim LT. Accuracy of surgeon-performed ultrasound in parathyroid localization. World J Surg. 2004;28:1122–6.PubMedCrossRef Van Husen R, Kim LT. Accuracy of surgeon-performed ultrasound in parathyroid localization. World J Surg. 2004;28:1122–6.PubMedCrossRef
17.
Zurück zum Zitat Kairys JC, Daskalakis C, Weigel RJ. Surgeon-performed ultrasound for preoperative localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. World J Surg. 2006;30:1658–63; (discussion 1664). Kairys JC, Daskalakis C, Weigel RJ. Surgeon-performed ultrasound for preoperative localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. World J Surg. 2006;30:1658–63; (discussion 1664).
18.
Zurück zum Zitat Solorzano CC, Carneiro-Pla DM, Irvin GL III. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2006;202:18–24.PubMedCrossRef Solorzano CC, Carneiro-Pla DM, Irvin GL III. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg. 2006;202:18–24.PubMedCrossRef
19.
Zurück zum Zitat Jabiev AA, Lew JI, Solorzano CC. Surgeon-performed ultrasound: a single-institution experience in parathyroid localization. Surgery. 2009;146:569–75; (discussion 575–567). Jabiev AA, Lew JI, Solorzano CC. Surgeon-performed ultrasound: a single-institution experience in parathyroid localization. Surgery. 2009;146:569–75; (discussion 575–567).
20.
Zurück zum Zitat Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212:522–9; (discussion 529–531). Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212:522–9; (discussion 529–531).
21.
Zurück zum Zitat Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–80; (discussion 380–373). Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242:375–80; (discussion 380–373).
22.
Zurück zum Zitat Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P. Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism. Pol Przegl Chir. 2013;85:598–604.PubMed Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P. Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism. Pol Przegl Chir. 2013;85:598–604.PubMed
23.
Zurück zum Zitat Irvin GL III, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA. 2000;284:934–6.PubMedCrossRef Irvin GL III, Carneiro DM. Management changes in primary hyperparathyroidism. JAMA. 2000;284:934–6.PubMedCrossRef
24.
Zurück zum Zitat Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.PubMedPubMedCentralCrossRef Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94:335–9.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Oltmann SC, Rajaei MH, Sippel RS, Chen H, Schneider DF. Primary hyperparathyroidism across the ages: presentation and outcomes. J Surg Res. 2014;190:185–90.PubMedCrossRef Oltmann SC, Rajaei MH, Sippel RS, Chen H, Schneider DF. Primary hyperparathyroidism across the ages: presentation and outcomes. J Surg Res. 2014;190:185–90.PubMedCrossRef
26.
Zurück zum Zitat Oltmann SC, Schneider DF, Sippel RS, Chen H. Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenarians. Ann Surg Oncol. 2013;20:4195–9.PubMedCrossRef Oltmann SC, Schneider DF, Sippel RS, Chen H. Presentation, management, and outcomes of hyperparathyroidism in octogenarians and nonagenarians. Ann Surg Oncol. 2013;20:4195–9.PubMedCrossRef
27.
Zurück zum Zitat Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks? World J Surg. 1998;22:531–5; (discussion 535–6). Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks? World J Surg. 1998;22:531–5; (discussion 535–6).
28.
Zurück zum Zitat Starker LF, Fonseca AL, Carling T, Udelsman R. Minimally invasive parathyroidectomy. Int J Endocrinol. 2011;2011:206502. Starker LF, Fonseca AL, Carling T, Udelsman R. Minimally invasive parathyroidectomy. Int J Endocrinol. 2011;2011:206502.
29.
Zurück zum Zitat Kebebew E, Duh QY, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138:867–71.PubMedCrossRef Kebebew E, Duh QY, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg. 2003;138:867–71.PubMedCrossRef
30.
Zurück zum Zitat Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, et al. Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg. 2004;131:628–32.PubMedCrossRef Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, et al. Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg. 2004;131:628–32.PubMedCrossRef
31.
Zurück zum Zitat Molinari AS, Irvin GL III,, Deriso GT, Bott L. Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery. 1996;120:934–6; (discussion 936–7). Molinari AS, Irvin GL III,, Deriso GT, Bott L. Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion. Surgery. 1996;120:934–6; (discussion 936–7).
32.
Zurück zum Zitat Lew JI, Irvin GL III. Focused parathyroidectomy guided by intraoperative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome. Surgery. 2009;146:1021–7.PubMedCrossRef Lew JI, Irvin GL III. Focused parathyroidectomy guided by intraoperative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome. Surgery. 2009;146:1021–7.PubMedCrossRef
33.
Zurück zum Zitat Mekel M, Gilshtein H, Chapchay K, Bishara B, Krausz MM, Freund HR, et al. Parathyroid surgery in the elderly: should minimally invasive surgery be abandoned? Ann Surg Oncol. 2014;21:1369–73.PubMedCrossRef Mekel M, Gilshtein H, Chapchay K, Bishara B, Krausz MM, Freund HR, et al. Parathyroid surgery in the elderly: should minimally invasive surgery be abandoned? Ann Surg Oncol. 2014;21:1369–73.PubMedCrossRef
Metadaten
Titel
Intraoperative Parathormone Monitoring Mitigates Age-Related Variability in Targeted Parathyroidectomy for Patients with Primary Hyperparathyroidism
verfasst von
Brian Bishop, BS
Bo Wang, MD
Punam P. Parikh, MD
John I. Lew, MD, FACS
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 3/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4843-2

Weitere Artikel der Sonderheft 3/2015

Annals of Surgical Oncology 3/2015 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.